Table 4.
Concordance among oral, fingernail, and vaginal samples* for type-specific HPV DNA detection among mid-adult women in Seattle, Washington, 2011–2012
| No. of pairs†
|
PPA (%)‡ | Kappa§ | (95% CI)¶ | ||||
|---|---|---|---|---|---|---|---|
| + / + | + / − | − /+ | − / − | ||||
| Oral / vaginal‖ | 2 | 17 | 520 | 28,580 | 0.37 | 0.01 | (0.00, 0.01) |
| Vaginal / fingernail | 11 | 334 | 6 | 18,408 | 3.13 | 0.03 | (0.01, 0.06) |
| Fingernail / oral | 2 | 15 | 9 | 18,807 | 7.69 | 0.08 | (0.00, 0.29) |
Enrollment and exit samples combined to calculate concordance between anatomic sites
Represents the number of women multiplied by the number of HPV types evaluated per woman multiplied by the number of samples evaluated per woman.
PPA is proportion positive agreement (number DNA-positive in both samples) / (number DNA-positive in either sample).
Kappa is calculated by (observed PPA – expected PPA) / (1 – expected PPA).
Confidence intervals estimated using percentile bootstrap methods with 1,000 repetitions to account for correlation due to multiple HPV types and dual visits within women
One pair with HPV-16 in oral and vaginal samples was considered (+ / −) due to detection of different variants in the oral versus the vaginal sample.